MYLK and breast cancer: The iCAFs of HR+/HER2-BC expressed pan-CAF markers such as PDPN, POSTN, DCN, FBLN1 and FAP, whereas, myCAF showed high levels of ACTA2, RGS5, MCAM, MYLK and PPP1R14A (Figure 4b).